EyePoint Pharmaceuticals资讯中心

H.C. Wainwright维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价22美元

富途资讯12/06 01:31

JonesTrading维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价45美元

富途资讯12/06 00:33

eyepoint pharmaceuticals价格目标保持在$22.00/Share，由HC Wainwright & Co。

道琼斯12/05 19:30

eyepoint pharmaceuticals 分析师评级

Benzinga12/05 19:21

JonesTrading维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价45美元

富途资讯12/03 06:31

贝雅维持EyePoint Pharmaceuticals(EYPT.US)买入评级，下调目标价至33美元

富途资讯11/11 20:31

JonesTrading维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价45美元

富途资讯11/11 20:31

H.C. Wainwright维持EyePoint Pharmaceuticals(EYPT.US)买入评级，下调目标价至22美元

富途资讯11/11 20:31

eyepoint pharmaceuticals被HC Wainwright & Co.维持为买入

道琼斯11/11 20:24

eyepoint pharmaceuticals股价目标由HC Wainwright & Co.下调至22.00美元/股，原先为30.00美元。

道琼斯11/11 20:24

Chardan Capital维持对eyepoint pharmaceuticals的买入评级，并将目标股价上调至33美元

Benzinga11/09 06:16

TD Cowen维持EyePoint Pharmaceuticals(EYPT.US)买入评级，下调目标价至20美元

富途资讯11/08 01:30

eyepoint pharmaceuticals：临床试验进展及有望的中期数据推动了买入评级

TipRanks11/08 00:50

丰业银行维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价18美元

富途资讯10/29 19:34

eyepoint pharmaceuticals被查丹资本维持买入评级

道琼斯10/29 19:11

eyepoint pharmaceuticals 分析师评级

Benzinga10/29 19:00

第一资本维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价35美元

富途资讯10/28 23:32

JonesTrading首予EyePoint Pharmaceuticals(EYPT.US)买入评级，目标价45美元

富途资讯10/28 22:32

贝雅维持EyePoint Pharmaceuticals(EYPT.US)买入评级，维持目标价38美元

富途资讯10/25 23:34

eyepoint pharmaceuticals的分析师评级

Benzinga10/25 22:02